SEC Form 4 · accession 0001061983-17-000057
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caryn Gordon McDowell
Officer — GC & Chief Compliance Officer
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2017 | S | 100 | $15.00 | D | 18,369 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $6.37 | Sep 6, 2017 | M | 5,732 | D | May 29, 2016 | May 29, 2025 | Common Stock | 5,732 | 18,857 | D |
| Incentive Stock Option (right to buy) | $6.67 | Sep 6, 2017 | M | 3,067 | D | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 3,067 | 23,715 | D |
| Non-Qualified Stock Option (right to buy) | $6.67 | Sep 6, 2017 | M | 1,432 | D | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 1,432 | 2,659 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.